approached significancep = 0.057
Gaming disorder scores also approached significance between non-clinical gamers and poly-substance use gamers ( p = 0.057). 4.
Gaming disorder scores also approached significance between non-clinical gamers and poly-substance use gamers ( p = 0.057). 4.
Steroid use showed a marginally non-significant correlation with reduced BMD ( p = 0.057).
Likewise, the effect of U67 on bone thickness was also enhanced, and that of U7M was also close to being significant ( p = 0.057).
Moreover, a marginally significant correlation was found between high-frequency PTA and the total score of MMSE (Rho = −0.283; p = 0.057).
In multivariate analysis, overlap syndromes (OR 1.85, CI 1.42–2.40; p < 0.001), arterial hypertension (OR 1.55, 95% CI 1.16–2.1; p = 0.003), SLE flare (OR 1.77, 95% CI 1.33–2.33; p < 0.001), and vascular events (OR 3.11, 95% CI 1.80–5.38; p < 0.001) remained independently associated with adverse outcomes, while antimalarial use showed a trend towards protection (OR 0.78, 95% CI 0.60–1.01; p = 0.057) ( Table 5 ).
It should be noted that the OT−0.3 mg/kg NTX combination only approached significance ( p = 0.057) though variability in response to the treatment was higher (coefficient of variation of 49.2) here than in other groups (OT + 0.1 mg/kg NTX: 46.5; OT + 1 mg/kg NTX: 41.8).
In the analysis of prognostic factors on hPFS, the number of initial metastases in Group C could be seen as a statistically significant factor ( p = 0.034) and trending towards significance in Group A ( p = 0.057).
But the difference in the prevalence of metabolic syndrome was marginally significant ( p = 0.057).
The time × condition effect was marginally significant for reactive aggression ( p = 0.057), with more improvement in the MCP group than in the CP group.
Comparing baseline protein levels with regard to diagnosis change to BD in the depressed subgroup during the study, we noticed a statistical trend towards lower EGF levels in the subgroup with diagnosis change ( p = 0.057).
A total of 562 patients (27.27%) were smokers—the prevalence of smoking was higher among men (30.20%; n = 289) compared to women (24.73%; n = 273); the difference was found to be statistically marginally significant ( p = 0.057).
The association between OAI and E/e’ at seven months also approached significance ( p = 0.057).
A history of chronic hypertension was notably more prevalent in the Preeclampsia group (33.3%) compared to the Normotensive group (17.7%), showing a strong trend toward significance ( p = 0.057).
The relationship between treatment type and tumor size approached significance but did not reach the conventional threshold, p = 0.057; the effect size was V = 0.36.
ΔBMI had a significant main effect on Emotional Symptoms [F(1, 31) = 10.55, p = 0.003, ƞ 2 p = 0.254], and a marginally significant effect on Total score of SDQ [F(1, 31) = 3.892, p = 0.057, ƞ 2 p = 0.112], suggesting that participants with greater changes in BMI, regardless of whether these changes constituted an increase or decrease, showed different overall levels of psychological adjustment.
CF cases carrying any SERPINA1 mutation showed a numerical increase in the number of mild exacerbations close to significance (10.7 (9.7) vs. 13.1 (12.1); p = 0.057), with no difference in severe exacerbations (2.1 (4.1) vs. 2.3 (3.1); p = 0.415) over the follow-up.
The pooled OR favored FD with an OR of 1.78 (95% CI: 0.98–3.24), although this trend narrowly missed statistical significance ( p = 0.0571).
27%; p = 0.0001) and showed a trend toward a higher rate of complete occlusion ( p = 0.0571).
However, the change in CES score between inclusion and the end of the study period was dependent on the ATE cluster ( p = 0.039) and ELA ( p = 0.0217), with a trend towards significance for diabetes ( p = 0.0574), sex ( p = 0.062), and pre-existing rheumatic disease ( p = 0.072) ( Supplementary Table S4 ; Figure 5 C).
In other comparisons, statistical significance was not achieved, though a favorable trend was noted for combination therapy in clinical remission outcomes ( p = 0.0578 vs. golimumab; p = 0.041 vs. guselkumab).
The β2-Glycoprotein I (β2-GP-I) test showed a near-significant correlation with IL-6 (r = 0.281, p = 0.058).
There was a negative trend for male gender and POPF (OR 0.729; 95% CI 0.526–1.011; p = 0.058).
Readmission demonstrated a trend toward significance favoring SDD (aOR 0.550, p = 0.058), while DVT showed no independent association ( p = 0.411; Table 6 ). 4.
[ 9 ] analyzed data from the MAGIC-MT, EMBOLISE, and STEM trials and found that MMAE reduced symptomatic progression or recurrence overall, although the result narrowly missed statistical significance (risk ratio (RR) 0.50, 95% CI 0.23–1.06; p = 0.058).
However, the post hoc analysis indicated a near-significant difference between obese and overweight participants ( p = 0.058), with obese participants displaying higher levels of bulimic tendencies (M = 3.50, SD = 3.89) compared to other BMI groups. 3.